Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

Related Citations for PubMed (Select 11593014)


The human decatenation checkpoint.

Deming PB, Cistulli CA, Zhao H, Graves PR, Piwnica-Worms H, Paules RS, Downes CS, Kaufmann WK.

Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12044-9. Epub 2001 Oct 2.


ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase.

Deming PB, Flores KG, Downes CS, Paules RS, Kaufmann WK.

J Biol Chem. 2002 Sep 27;277(39):36832-8. Epub 2002 Jul 29.


Degradation of ATM-independent decatenation checkpoint function in human cells is secondary to inactivation of p53 and correlated with chromosomal destabilization.

Kaufmann WK, Campbell CB, Simpson DA, Deming PB, Filatov L, Galloway DA, Zhao XJ, Creighton AM, Downes CS.

Cell Cycle. 2002 May-Jun;1(3):210-9.


Revised genetic requirements for the decatenation G2 checkpoint: the role of ATM.

Bower JJ, Zhou Y, Zhou T, Simpson DA, Arlander SJ, Paules RS, Cordeiro-Stone M, Kaufmann WK.

Cell Cycle. 2010 Apr 15;9(8):1617-28. Epub 2010 Apr 15.


Rad9A is required for G2 decatenation checkpoint and to prevent endoreduplication in response to topoisomerase II inhibition.

Greer Card DA, Sierant ML, Davey S.

J Biol Chem. 2010 May 14;285(20):15653-61. doi: 10.1074/jbc.M109.096156. Epub 2010 Mar 21.


Bleomycin-induced over-replication involves sustained inhibition of mitotic entry through the ATM/ATR pathway.

Nakayama Y, Igarashi A, Kikuchi I, Obata Y, Fukumoto Y, Yamaguchi N.

Exp Cell Res. 2009 Sep 10;315(15):2515-28. doi: 10.1016/j.yexcr.2009.06.007. Epub 2009 Jun 13.


Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.

Tsvetkov L, Stern DF.

Cell Cycle. 2005 Jan;4(1):166-71. Epub 2005 Jan 5.


Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1.

Park I, Avraham HK.

Exp Cell Res. 2006 Jul 1;312(11):1996-2008. Epub 2006 Apr 21.


4-Hydroxynonenal induces G2/M phase cell cycle arrest by activation of the ataxia telangiectasia mutated and Rad3-related protein (ATR)/checkpoint kinase 1 (Chk1) signaling pathway.

Chaudhary P, Sharma R, Sahu M, Vishwanatha JK, Awasthi S, Awasthi YC.

J Biol Chem. 2013 Jul 12;288(28):20532-46. doi: 10.1074/jbc.M113.467662. Epub 2013 Jun 3.


FGF inhibits the activity of the cyclin B1/CDK1 kinase to induce a transient G₂arrest in RCS chondrocytes.

Tran T, Kolupaeva V, Basilico C.

Cell Cycle. 2010 Nov 1;9(21):4379-86. Epub 2010 Nov 15.


Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling.

Jurvansuu J, Fragkos M, Ingemarsdotter C, Beard P.

J Mol Biol. 2007 Sep 14;372(2):397-406. Epub 2007 Jul 3.


The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe.

Castedo M, Perfettini JL, Roumier T, Yakushijin K, Horne D, Medema R, Kroemer G.

Oncogene. 2004 May 27;23(25):4353-61.


Regulation of mitotic entry by microcephalin and its overlap with ATR signalling.

Alderton GK, Galbiati L, Griffith E, Surinya KH, Neitzel H, Jackson AP, Jeggo PA, O'Driscoll M.

Nat Cell Biol. 2006 Jul;8(7):725-33. Epub 2006 Jun 18.


p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress.

Charrier-Savournin FB, Château MT, Gire V, Sedivy J, Piette J, Dulic V.

Mol Biol Cell. 2004 Sep;15(9):3965-76. Epub 2004 Jun 4.


RAC1 GTPase plays an important role in γ-irradiation induced G2/M checkpoint activation.

Yan Y, Greer PM, Cao PT, Kolb RH, Cowan KH.

Breast Cancer Res. 2012 Apr 11;14(2):R60.


Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation.

Gatei M, Sloper K, Sorensen C, Syljuäsen R, Falck J, Hobson K, Savage K, Lukas J, Zhou BB, Bartek J, Khanna KK.

J Biol Chem. 2003 Apr 25;278(17):14806-11. Epub 2003 Feb 14.


Artemis links ATM to G2/M checkpoint recovery via regulation of Cdk1-cyclin B.

Geng L, Zhang X, Zheng S, Legerski RJ.

Mol Cell Biol. 2007 Apr;27(7):2625-35. Epub 2007 Jan 22.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk